Saturday, 18 August 2018 - 8:11
  • it
  • de
  • en
  • fr


UCB sold Innere Medizin to private equity

UCB has announced it has sold its German subsidiary Innere Medizin to private equity Paragon Partners. Innere Medizin employs 200 people and markets pharmaceutical specialties in German speaking countries. The parties have not provided the financial details of the transaction….

Biogen and UCB targeting Acorda Therapeutics (€1bn)

US-based Acorda Therapeutics (New York) is reportedly targeted by Belgium-based UCB, the Belgian daily De Tijd has reported today. Acorda Therapeutics is worth approximately $1bn, according to analysts (Bloomberg). Due to pressure by shareholders, Acorda’s management in August put the…